Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8


A Dose-escalation Study of Recombinant Human Interleukin-18 in Combination With Ofatumumab After Autologous Peripheral Blood Stem Cell Transplantation for Lymphoma.

Robertson MJ, Stamatkin CW, Pelloso D, Weisenbach J, Prasad NK, Safa AR.

J Immunother. 2018 Apr;41(3):151-157. doi: 10.1097/CJI.0000000000000220.


Soypeptide lunasin in cytokine immunotherapy for lymphoma.

Chang HC, Lewis D, Tung CY, Han L, Henriquez SM, Voiles L, Lupov IP, Pelloso D, Sinn AL, Pollok KE, de Lumen BO, Li F, Blum JS, Srivastava S, Robertson MJ.

Cancer Immunol Immunother. 2014 Mar;63(3):283-95. doi: 10.1007/s00262-013-1513-8. Epub 2013 Dec 22.


Effects of interleukin-18 on natural killer cells: costimulation of activation through Fc receptors for immunoglobulin.

Srivastava S, Pelloso D, Feng H, Voiles L, Lewis D, Haskova Z, Whitacre M, Trulli S, Chen YJ, Toso J, Jonak ZL, Chang HC, Robertson MJ.

Cancer Immunol Immunother. 2013 Jun;62(6):1073-82. doi: 10.1007/s00262-013-1403-0. Epub 2013 Apr 19.


Acquired STAT4 deficiency as a consequence of cancer chemotherapy.

Lupov IP, Voiles L, Han L, Schwartz A, De La Rosa M, Oza K, Pelloso D, Sahu RP, Travers JB, Robertson MJ, Chang HC.

Blood. 2011 Dec 1;118(23):6097-106. doi: 10.1182/blood-2011-03-341867. Epub 2011 Oct 13.


Impaired development of human Th1 cells in patients with deficient expression of STAT4.

Chang HC, Han L, Goswami R, Nguyen ET, Pelloso D, Robertson MJ, Kaplan MH.

Blood. 2009 Jun 4;113(23):5887-90. doi: 10.1182/blood-2008-09-179820. Epub 2009 Apr 9.


Immunological consequences of interleukin 12 administration after autologous stem cell transplantation.

Pelloso D, Cyran K, Timmons L, Williams BT, Robertson MJ.

Clin Cancer Res. 2004 Mar 15;10(6):1935-42.


Interleukin 12 immunotherapy after autologous stem cell transplantation for hematological malignancies.

Robertson MJ, Pelloso D, Abonour R, Hromas RA, Nelson RP Jr, Wood L, Cornetta K.

Clin Cancer Res. 2002 Nov;8(11):3383-93.

Supplemental Content

Loading ...
Support Center